Markets

Market Nav

BALANCE SHEET

You can view the balance sheet for the last 5 years.

Marksans Pharma Ltd.

May 08 BSE 159.30 (+ 1.50 0.95%)

Volume106758

Prev. Close
157.80

Open Price
157.10

Today's Low / High

155.95 162.35

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

70.20 185.40

May 08 NSE 159.55(+ 1.65 1.04%)

Volume1387108

Prev. Close
157.90

Open Price
156.90

Today's Low / High

155.10 162.70

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

70.55 185.50

(₹ in Crs.)

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00
No. of Equity Shares (in Lacs)	4531.64	4093.14	4093.14	4093.14	4093.14

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	45.32	40.93	40.93	40.93	40.93
Preference Share Capital	0.00	0.00	0.00	0.00	10.00
Total Share Capital	45.32	40.93	40.93	40.93	50.93

Reserves and Surplus	1699.85	1161.34	845.56	595.08	501.55
Total Reserves and Surplus	1699.85	1161.34	845.56	595.08	501.55
Total Shareholders Funds	1745.16	1202.27	886.49	636.01	552.48
Minority Interest	19.91	20.70	18.86	13.11	10.22

NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	15.39	17.62	8.06	10.79	7.03
Other Long Term Liabilities	65.69	41.43	14.33	12.52	0.00
Long Term Provisions	3.25	1.86	2.11	1.47	1.36
Total Non-Current Liabilities	84.33	60.91	24.50	24.79	8.39

CURRENT LIABILITIES
Short Term Borrowings	41.59	41.29	18.74	18.84	99.91
Trade Payables	230.60	200.08	168.66	110.33	106.07
Other Current Liabilities	67.48	114.12	109.14	70.72	25.81
Short Term Provisions	1.33	0.72	1.85	28.86	0.84
Total Current Liabilities	340.99	356.22	298.40	228.75	232.62

Total Capital And Liabilities	2190.39	1640.10	1228.25	902.67	803.71

ASSETS
NON-CURRENT ASSETS
Tangible Assets	379.64	341.59	248.42	230.01	198.08
Intangible Assets	68.17	56.69	60.94	72.70	71.64
Capital Work-In-Progress	7.25	0.70	5.60	0.00	0.00
Intangible Assets Under Development	2.62	1.88	6.08	0.00	0.00
Fixed Assets	457.69	400.86	321.04	302.72	269.73
Goodwill On Consolidation	38.49	30.03	0.00	0.00	0.00
Deferred Tax Assets [Net]	0.00	3.86	0.80	0.63	1.25
Other Non-Current Assets	18.91	4.16	4.16	5.73	1.29
Total Non-Current Assets	515.09	438.90	326.00	309.08	272.27


CURRENT ASSETS
Current Investments	0.54	0.44	0.00	0.00	0.00
Inventories	484.74	424.44	404.32	241.84	293.25
Trade Receivables	416.85	394.78	271.38	243.35	176.60
Cash And Cash Equivalents	714.96	349.27	212.29	93.73	33.54
OtherCurrentAssets	58.21	32.28	14.26	14.67	28.06
Total Current Assets	1675.30	1201.20	902.25	593.59	531.44

Total Assets	2190.39	1640.10	1228.25	902.67	803.71

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	9.31	17.02	19.78	48.17	30.40

Particulars	Mar 23
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	1.00
No. of Equity Shares (in Lacs)	4531.64

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	45.32
Preference Share Capital	0.00
Total Share Capital	45.32
Reserves and Surplus	1699.85
Total Reserves and Surplus	1699.85
Total Shareholders Funds	1745.16
Minority Interest	19.91
NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	15.39
Other Long Term Liabilities	65.69
Long Term Provisions	3.25
Total Non-Current Liabilities	84.33
CURRENT LIABILITIES
Short Term Borrowings	41.59
Trade Payables	230.60
Other Current Liabilities	67.48
Short Term Provisions	1.33
Total Current Liabilities	340.99
Total Capital And Liabilities	2190.39
ASSETS
NON-CURRENT ASSETS
Tangible Assets	379.64
Intangible Assets	68.17
Capital Work-In-Progress	7.25
Intangible Assets Under Development	2.62
Fixed Assets	457.69
Goodwill On Consolidation	38.49
Deferred Tax Assets [Net]	0.00
Other Non-Current Assets	18.91
Total Non-Current Assets	515.09
CURRENT ASSETS
Current Investments	0.54
Inventories	484.74
Trade Receivables	416.85
Cash And Cash Equivalents	714.96
OtherCurrentAssets	58.21
Total Current Assets	1675.30
Total Assets	2190.39
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	9.31